Literature DB >> 3734455

Hypertension control in two Canadian communities: evidence for better treatment and overlabelling.

N J Birkett, C E Evans, R B Haynes, D W Taylor, D L Sackett, J R Gilbert, M E Johnston, S A Hewson, L A Macdonald.   

Abstract

We evaluated the prevalence and control of hypertension in two Canadian cities without university medical centre facilities. A stratified multistage probability sample was selected, and we interviewed 6258 adults between the ages of 30 and 69 inclusive. Blood pressure measurements were obtained during home interviews. Up to two further visits were made to people with untreated blood pressure elevation. By a diagnostic criterion of 90 mmHg, the hypertension prevalence was 114/1000. Six per cent of the hypertensives were undetected, 6% detected but untreated, 17% treated but uncontrolled and 70% were being treated and controlled. Control was better in females and older subjects. These findings show no disadvantages to hypertensives living away from university medical centres. We found a hypertension prevalence of 143/1000 among people who reported being diagnosed as hypertensive but who had normal blood pressure while not on medication. These results suggest a problem with over-labelling of hypertensives.

Entities:  

Mesh:

Year:  1986        PMID: 3734455     DOI: 10.1097/00004872-198606000-00019

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  2 in total

1.  The Saskatchewan Heart Foundation Blood Pressure Survey: The efficacy of community-based detection and referral programs.

Authors:  T W Wilson; M Dubois; V Ramsden; P Raina; L K Tan
Journal:  Can Fam Physician       Date:  1991-03       Impact factor: 3.275

Review 2.  Report of the Canadian Hypertension Society Consensus Conference: 2. Diagnosis of hypertension in adults.

Authors:  R B Haynes; Y Lacourcière; S W Rabkin; F H Leenen; A G Logan; N Wright; C E Evans
Journal:  CMAJ       Date:  1993-08-15       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.